KLK3 and prostate neoplasm: This was mainly because our study assessed PCa patients with PSA levels of 4–20 ng/ml and mainly focused on intra-prostatic tumours rather than metastatic PCa lesions or patients with PSA levels ≥ 20 ng/ml.